GleamWall
中文EN

CSBR CHAMPIONS ONCOLOGY, INC.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 771856 · Fiscal year ends 04/30

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.7%
TTM net income YoY-137.8%
TTM EPS YoY—
Revenue 3-yr CAGR4.8%
Net income 3-yr CAGR—

Margins

Gross margin49.8%
Operating margin-1.7%
Net margin-1.8%
FCF margin-10.1%
EBITDA margin0.5%

Returns

ROE-29.8%
ROA-3.5%
ROIC (approx.)—
Asset turnover1.90x

Leverage & solvency

Liabilities / assets86.6%
Debt / equity0.00x
Current ratio1.03x
Interest coverage—

Cash quality & payout

Operating cash flow / net income5.04x
Accruals ratio14.0%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-04-30FY20252025-04-30
Income statement
Revenue$59.42M$56.94M
Cost of revenue$30.90M$28.39M
Gross profit$28.52M$28.55M
R&D expense$9.08M$6.83M
SG&A expense$11.15M$9.34M
Operating income-$1.14M$4.55M
Pretax income-$929,000$4.63M
Income tax$246,000-$75,000
Net income-$1.18M$4.70M
EBITDA$260,000$6.15M
EPS (basic)-0.080.34
EPS (diluted)-0.080.33
Weighted avg. shares (diluted)13.83M14.27M
Balance sheet
Cash & equivalents$4.87M$9.79M
Receivables$13.18M$11.20M
Current assets$19.22M$22.36M
PP&E, net$3.53M$4.38M
Goodwill$335,000$335,000
Total assets$26.99M$32.34M
Current liabilities$19.92M$23.85M
Total liabilities$22.92M$28.57M
Shareholders' equity$3.94M$3.77M
Shares outstanding13.89M13.78M
Cash flow statement
Operating cash flow-$4.47M$7.39M
Capital expenditure$564,000$389,000
Free cash flow-$5.04M$7.00M
Investing cash flow-$540,000-$389,000
Financing cash flow$99,000$170,000
Depreciation & amortization$1.40M$1.60M
Stock-based compensation$1.24M$654,000
Share buybacks—$0

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.